In Vitro Susceptibilities of Rapidly Growing Mycobacteria to Telithromycin (HMR 3647) and Seven Other Antimicrobials | Zendy

R. FernándezRoblas | Zendy; Jaime Esteban | Zendy; F. Cabria | Zendy; Juan C. López | Zendy; María Soledad Jiménez | Zendy; Francisco García Soriano | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In Vitro Susceptibilities of Rapidly Growing Mycobacteria to Telithromycin (HMR 3647) and Seven Other Antimicrobials

Author(s) -

R. FernándezRoblas,

Jaime Esteban,

F. Cabria,

Juan C. López,

María Soledad Jiménez,

Francisco García Soriano

Publication year - 2000

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.44.1.181-182.2000

Subject(s) - mycobacterium fortuitum , telithromycin , mycobacterium chelonae , microbiology and biotechnology , antimicrobial , mycobacterium , mycobacterium abscessus , antibiotics , antibacterial agent , biology , bacteria , genetics

The antimicrobial activities of telithromycin (HMR 3647) and seven other antimicrobials against 94 strains of rapidly growing mycobacteria were determined. Telithromycin at a concentration of 1 microg/ml inhibited Mycobacterium peregrinum (100%), Mycobacterium chelonae (80%), Mycobacterium abscessus-Mycobacterium mucogenicum (44.4%), and Mycobacterium fortuitum (2.1%). All or most strains of M. peregrinum, M. fortuitum, and M. mucogenicum were inhibited by 2 microg of quinolones per ml.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research